Our translational research focuses on the genetic and molecular basis of human disease with a particular interest in cancer and inherited conditions. 🧬🔬
📢📢FINAL CALL!! Closes tomorrow (Mon 20th Oct)
Want a cool, blue skies project, integrating machine learning with virology to develop the medicines 💊of the future?
Want to join a team with an incredible culture?
Apply now! 🧬🔬🧪🦠👨🔬👩🔬
https://t.co/s8TDEnkyZY
Join our new Wales Applied Virology Unit as a Lecturer in Infectious Disease Epidemiology / Behavioural Science!
See the advert here
https://t.co/kZaw3KWKwB
And contact WAVU co-director David Gillespie for informal enquiries.
#NewPI#Lecturer#GroupLeader#Job#Opportunity
What an opportunity here for a new group leader to join us as a lecturer in virology/vaccines/ATMPs working between the division of cancer and genetics, division of infection and immunity and the centre for trials research…comes with a PhD student too! 👍🏻🦠👍🏻
psst...want to hear a great #Virology opportunity? We have an amazing opportunity for a new PI/#Lecturer/group leader in virology/viral immunology @cardiffuni as part of a new @ResearchWales funded Virology unit headed by myself, @StantonRich@DaveGuk87 🦠
https://t.co/RJnNAZwWVo
Three technical posts available in the school of medicine - an opportunity for someone to begin their technical journey in a permanent post…have a look and apply if you like the sound of it!
An opportunity for three core junior technical members of staff to join the medical school here at Cardiff University. One may even be based partly in our @virustinkerer lab - see advert here:
https://t.co/pvRp5kbNXJ
📣Thrilled to share that our paper describing a smart virus capable of delivering "in tumour chemotherapy" for pancreatic cancer is now published online 🎉 Read all about it here:
https://t.co/4RMXd6xC32
New cancer therapeutic originally developed with DCG’s @virustinkerer lab headed by @alanlparker set to enter the clinic after clinical trial application submitted to MHRA @theWCRC@cardiffuni
Delighted to report Accession Therapeutics have submitted a clinical trial application and expect first patient to be treated with Trocept-01 in 2024. The underlying technology was developing @virustinkerer lab @cardiffuni. Amazing progress.
https://t.co/RU2iDAOWzF
Our seminar series restarts 17/09 and kicks off with Prof Aled Clayton discussing biomarkers of prostate cancer and the development of a blood based assay. Be sure to join us for his talk!
Our 2024/2025 DCG #seminar series is back with a bang! Join us as Director of #Research Aled Clayton updates us on his quest to find markers for #Prostate#Cancer and generate blood based assays. For non-DCG who wish to join with zoom, please contact [email protected].
For anyone at the Eisteddfod today, please visit team @virustinkerer at the Science and Technology Village to "build a virus" and learn all about future cancer treatments! We look forward to seeing you!
Have a sneak peek of our latest review, as we have preprinted it whilst it undergoes formal review. Well done @Rebecca_Wxx for penning the majority of this extensive and timely review...
The Immune System – Friend or Foe for Adenovirus Based Therapies?https://t.co/L2VLYMBHVS
Want to join our thriving @virustinkerer
lab, on a fully funded 🎉4 year 📷PhD? A Mowasi Scholarship available from Oct to develop molecular switches to control "smart viruses" to treat #Glioma#GBM#BrainCancer#DIPG#DMG please share/RT.
https://t.co/gQegH7s8dJ